[
  {
    "ts": null,
    "headline": "Why AbbVie Remains A Strong Buy For Long-Term Investors",
    "summary": "Discover why AbbVie stands out for long-term investors with strong growth in Skyrizi & Qulipta sales.",
    "url": "https://finnhub.io/api/news?id=836f08a1663641b8706ac500a6f262775dee09979e358bb4eed589b52a232408",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740311542,
      "headline": "Why AbbVie Remains A Strong Buy For Long-Term Investors",
      "id": 132858207,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/172165367/image_172165367.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Discover why AbbVie stands out for long-term investors with strong growth in Skyrizi & Qulipta sales.",
      "url": "https://finnhub.io/api/news?id=836f08a1663641b8706ac500a6f262775dee09979e358bb4eed589b52a232408"
    }
  }
]